Sai-Wen has 15 years of research experience in cancer therapy, molecular biology and cell biology with strong publication record. He is skilled to develop immune cell therapy with CAR-T technology. At Acepodia, Sai-Wen is responsible for novel platform/pipeline development and translational study. Before joining Acepodia, Sai-Wen was working on development of CAR-Treg for autoimmune diseases at Stanford University. He received postdoctoral training at National Institute of Allergy and Infectious Diseases and National Cancer Institute, National Institutes of Health, and was awarded NCI CCR Federal Technology Transfer Award (2015).

Location: Vallejo, California, United States

LinkedIn: www.linkedin.com/in/saiwentang/

For contact information, please email james.milburn@hansonwade.com